Endpoints Newsnews

XTL Bio to acquire psychedelic biotech; WuXi AppTec’s Q1 revenue rise

Thursday, April 30, 2026Anna BrownView original
Plus, news about PCI Pharma: 🏭 XTL Bio steps into psychedelics: XTL Biopharmaceuticals is acquiring 100% of the outstanding shares of psychedelic-focused biotech Psyga Bio. XTL will gain Psyga’s manufacturing facility ...

Read the full article on the original site.

Read Full Article